Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
131 hedge funds and large institutions have $752M invested in Exact Sciences in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 16 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 43
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
2% more funds holding
Funds holding: 129 → 131 (+2)
0% more capital invested
Capital invested by funds: $749M → $752M (+$2.59M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
22% less call options, than puts
Call options by funds: $18M | Put options by funds: $23M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$24.2M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$13.1M |
| 3 |
Goldman Sachs
New York
|
+$11.3M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$7.65M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
+$6.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$27.5M |
| 2 |
JP Morgan Chase
New York
|
-$25.3M |
| 3 |
CCI
Columbus Circle Investors
|
-$17M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.57M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.59M |
EXAS Hedge Fund Activity: Q4 2013 in Review
131 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2013, worth a combined $752M — up 0.35% from $749M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new EXAS positions and 16 closed out — a net gain of 2 holders — while 52 added to existing stakes and 43 trimmed.
The largest buyer was Granahan Investment Management, opening a new position worth an estimated $24.2M. The largest seller was Jennison Associates, cutting an estimated $27.5M.
- 131 institutional investors held Exact Sciences (EXAS) as of Q4 2013, up from 129 in Q3 2013.
- Funds reported $752M of Exact Sciences stock for Q4 2013, up 0.35% quarter-over-quarter.
- 18 funds opened new Exact Sciences positions in Q4 2013 and 16 closed out, a net change of +2 holders.
- The largest Exact Sciences buyer in Q4 2013 was Granahan Investment Management, an estimated $24.2M added.
- The largest Exact Sciences seller in Q4 2013 was Jennison Associates, an estimated $27.5M sold.
Based on aggregated 13F filings for Q4 2013.